What is Keratinocyte carcinoma (skin cancer) signs?
Keratinocyte carcinoma (KC) is an umbrella term for two of the most common types of skin cancer:
- Basal cell carcinoma (BCC) â arises from the basal cells at the bottom of the epidermis.
- Squamous cell carcinoma (SCC) â arises from the keratinâproducing squamous cells in the outer layers of the skin.
Both cancers develop from keratinocytes, the predominant cell type in the epidermis that produces the protein keratin. While KC is usually slowâgrowing and rarely spreads (metastasizes) when caught early, it can become locally invasive and cause significant tissue damage if left untreated.
The term âsignsâ refers to the visible or palpable changes on the skin that alert patients and clinicians to the possible presence of KC. Recognizing these signs early is essential for prompt treatment and better outcomes.
Common Causes
Keratinocyte carcinoma is primarily caused by DNA damage to skin cells. The most important risk factors include:
- Ultraviolet (UV) radiation â chronic exposure to sunlight or tanning beds.
- Fair skin, red or blond hair, and light eye color â less melanin provides less natural protection.
- History of sunburns, especially blistering burns in childhood.
- Age â incidence rises sharply after age 50.
- Immunosuppression â organâtransplant recipients, HIV infection, or chronic corticosteroid use.
- Chronic skin injury or inflammation â scars, burns, or longâstanding wounds (Marjolin ulcer).
- Human papillomavirus (HPV) infection â particularly highârisk types linked to SCC of the genitalia and perianal skin.
- Exposure to certain chemicals â arsenic, tar, coal dust, and some industrial solvents.
- Genetic syndromes â such as Gorlin syndrome (basal cell nevus) or xeroderma pigmentosum.
- Radiation therapy â prior therapeutic radiation can predispose to SCC in the treated field.
Associated Symptoms
While KC often presents as a solitary skin change, other symptoms may accompany the primary lesion, especially in more advanced disease:
- Itching or tenderness around the lesion.
- Bleeding or crusting that does not heal within a few weeks.
- Painful ulceration â more common with SCC.
When to See a Doctor
Because early KC can mimic harmless skin changes, itâs important to act when any of the following occur:
- A new spot on the skin that continues to grow after 2â3 weeks.
- Any lesion that bleeds, oozes, or forms a crust that does not resolve.
- Changes in size, shape, color, or texture of an existing mole or spot.
- A sore that reâopens after healing.
- Persistent itching, tenderness, or pain in a localized area.
- Any lesion on a highârisk site (ears, lips, scalp, hands, or genital area).
Prompt evaluation by a dermatologist or primaryâcare clinician can prevent larger, more invasive tumors.
Diagnosis
Diagnosis of keratinocyte carcinoma combines a visual exam with tissue sampling and, when needed, imaging.
1. Clinical Examination
- Dermatologist uses a dermatoscope (magnifying device) to assess pattern, vascular structures, and pigment.
- Application of the âABCDEâ checklist (though originally for melanoma) helps rule out other cancers.
2. Biopsy
Histopathology is the goldâstandard. Common biopsy techniques include:
- Punch biopsy â a circular blade removes a core of tissue.
- Shave biopsy â a superficial slice for lesions that appear thin.
- Excisional biopsy â complete removal of the lesion when it is small enough.
The pathologist classifies the tumor (BCC vs. SCC), determines its depth, and checks for aggressive features such as perineural invasion.
3. Imaging (when needed)
- Highâfrequency ultrasound or MRI to assess depth and involvement of underlying structures.
- CT or PETâCT for suspected metastasis in highârisk SCC.
4. Staging
For SCC, especially highârisk tumors, clinicians may use the AJCC (American Joint Committee on Cancer) staging system based on tumor size, depth, differentiation, perineural invasion, and nodal involvement.
Treatment Options
Therapy is individualized based on tumor type, size, location, patient health, and cosmetic considerations.
1. Surgical Treatments
- Standard excision â removal with a margin of normal skin (typically 4â6âŻmm for BCC, 6â10âŻmm for SCC).
- Mohs micrographic surgery â layerâbyâlayer removal with immediate microscopic examination. Highest cure rate (>99%) for facial or highârisk lesions.
- Curettage and electrodessication (C&E) â scraping the tumor followed by cauterization. Useful for lowârisk, superficial BCC.
- Cryotherapy â freezing the lesion with liquid nitrogen; effective for small, superficial cancers.
2. NonâSurgical Treatments
- Topical therapies
- 5âFluorouracil (5âFU) cream â DNA synthesis inhibitor for superficial BCC/SCC.
- Imiquimod cream â immune response modifier for superficial BCC.
- Photodynamic therapy (PDT) â application of a photosensitizing agent followed by light activation; excellent cosmetic results for superficial lesions.
- Radiation therapy â external beam radiation for patients who cannot undergo surgery or for unresectable tumors.
- Targeted systemic therapy
- Hedgehog pathway inhibitors (vismodegib, sonidegib) for advanced/metastatic BCC.
- Cetuximab or pembrolizumab (PDâ1 inhibitor) for select advanced SCC.
3. Supportive & Home Care
- Keep the wound clean and covered as directed.
- Apply prescribed topical agents exactly as instructed.
- Protect healing skin from sun exposure (broadâspectrum SPFâŻ30+).
- Report any excessive pain, bleeding, or rapid changes to your clinician.
Prevention Tips
Because UV exposure is the chief modifiable risk factor, most prevention strategies focus on sun protection and skin surveillance.
- Use sunscreen daily â broadâspectrum SPFâŻ30 or higher; reapply every 2âŻhours outdoors.
- Seek shade during peak sun hours (10âŻamâ4âŻpm).
- Wear protective clothing â longâsleeved shirts, wideâbrim hats, and UVâblocking sunglasses.
- Avoid indoor tanning â UVâemitting beds increase KC risk as much as 2âfold.
- Perform regular skin selfâexams â monthly checks for new or changing lesions.
- Schedule professional skin exams â at least yearly for average risk; every 6âŻmonths for highârisk individuals.
- Quit smoking â tobacco compounds can impair immune surveillance and worsen SCC outcomes.
- Maintain a healthy immune system â stay up to date on vaccinations and manage chronic illnesses.
Emergency Warning Signs
- Sudden, severe bleeding from a skin lesion that does not stop with pressure.
- Rapidly enlarging ulcer that penetrates deep tissue or appears to be spreading.
- Severe, worsening pain that is unrelieved by overâtheâcounter pain medication.
- Signs of infection: fever, chills, red streaks spreading from the lesion, or pus formation.
- Difficulty breathing, swallowing, or speaking when a lesion is located on the mouth, throat, or neck.
- Numbness or loss of sensation around a lesion, suggesting nerve involvement.
References
- Mayo Clinic. âBasal cell skin cancer.â https://www.mayoclinic.org
- Mayo Clinic. âSquamous cell skin cancer.â https://www.mayoclinic.org
- American Cancer Society. âSkin Cancer Prevention.â https://www.cancer.org
- Cleveland Clinic. âBasal Cell Carcinoma Treatment Options.â https://my.clevelandclinic.org
- National Cancer Institute. âTreatment of Squamous Cell Skin Cancer.â https://www.cancer.gov
- World Health Organization. âUltraviolet radiation and skin cancer.â https://www.who.int
- American Academy of Dermatology. âSkin Cancer Facts and Statistics.â https://www.aad.org